《儿童和青少年1型糖尿病的分期》2022国际儿童青少年糖尿病学会临床实践指南解读和评述

Interpretation and comments on ISPAD clinical practice consensus guideline of stages of type 1 diabetes in children and adolescents

1型糖尿病(T1DM)是儿童自身免疫性疾病之一,迄今缺乏有效的预防和治愈方法。2022年,国际儿童青少年糖尿病学会发布《儿童青少年1型糖尿病分期临床实践指南》,进一步阐述了T1DM风险、分期、无症状期筛查和监测及其由此带来的精神心理和经济负担,并讨论了延缓T1DM进展的策略以及有效保护患者残留β细胞功能的措施和最新研究成果,为临床T1DM的早期发现、早期干预提供了详实的指导建议,具有重要的参考价值。

Type 1 diabetes mellitus(T1DM)is one of children′s autoimmune diseases with no effective method for prevention and treatment.International Society for Pediatric and Adolescent Diabetes published clinical practice consensus guidelines 2022:stages of type 1 diabetes in children and adolescents,which further elaborated the risk and the stages of T1DM,the screening and monitoring for pre-symptomatic T1DM,as well as the resulting psychological and economic burden.The guideline aslo discussed the interventions to halt the disease,the effective measures and the latest research results to preserve residualβ-cell function,which provided detailed guidance and suggestions for the early detection and early intervention of clinical T1DM and important reference value.